Villarante, Bb Girl Ii .

HRN: 27-27-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2025
AMPICILLIN 250MG (VIAL)
06/17/2025
06/25/2025
IV
130mg
Q12
PSNB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines